Thu, September 28, 2023
Wed, September 27, 2023
Tue, September 26, 2023
Mon, September 25, 2023
Fri, September 22, 2023
Thu, September 21, 2023

Brian Cheng Maintained (BCAB) at Buy with Decreased Target to $14 on, Sep 25th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-14-on-sep-25th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Cheng of JP Morgan, Maintained "BioAtla, Inc." (BCAB) at Buy with Decreased Target from $17 to $14 on, Sep 25th, 2023.

Brian has made no other calls on BCAB in the last 4 months.



There are 3 other peers that have a rating on BCAB. Out of the 3 peers that are also analyzing BCAB, 0 agree with Brian's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Brian


  • Arthur He of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $17 on, Wednesday, August 2nd, 2023
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $12 on, Wednesday, August 2nd, 2023
  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $25 on, Wednesday, August 2nd, 2023

Publication Contributing Sources